SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-303088
Filing Date
2021-10-20
Accepted
2021-10-20 16:30:49
Documents
14
Period of Report
2021-10-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d242793d8k.htm   iXBRL 8-K 29937
2 EX-99.1 d242793dex991.htm EX-99.1 6416
6 GRAPHIC g242793g1020002836305.jpg GRAPHIC 4751
  Complete submission text file 0001193125-21-303088.txt   166541

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gh-20211015.xsd EX-101.SCH 2893
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE gh-20211015_lab.xml EX-101.LAB 17375
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gh-20211015_pre.xml EX-101.PRE 10956
7 EXTRACTED XBRL INSTANCE DOCUMENT d242793d8k_htm.xml XML 3220
Mailing Address 505 PENOBSCOT DR. REDWOOD CITY CA 94063
Business Address 505 PENOBSCOT DR. REDWOOD CITY CA 94063 855-698-8887
Guardant Health, Inc. (Filer) CIK: 0001576280 (see all company filings)

IRS No.: 454139254 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38683 | Film No.: 211334514
SIC: 8071 Services-Medical Laboratories